Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Fokas

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 13, 2021
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in GermanyDavid Krug, Markus Hecht, Nadja Ebert, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trialsDario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute|July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, C David Fuller, Shalini Moningi, et al.
Journal of Neuro-Oncology|July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysisAnna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
International Journal of Cancer|May 9, 2017
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Panagiotis Balermpas, Franz Rödel, Mechthild Krause, et al.
Plos One|April 29, 2017
An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouseVeerle Kersemans, John S Beech, Stuart Gilchrist, et al.
Cancer Cell|February 5, 2022
Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancerAdele M Nicolas, Marina Pesic, Esther Engel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Performance Status Restriction in Phase III Cancer Clinical TrialsJoseph Abi Jaoude, Ramez Kouzy, Walker Mainwaring, et al.
JAMA Oncology|November 18, 2021
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical TrialEmmanouil Fokas, Anke Schlenska-Lange, Bülent Polat, et al.
International Journal of Cancer|December 14, 2017
Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Stefan Stangl, Nikoletta Tontcheva, Wolfgang Sievert, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 13, 2021
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in GermanyDavid Krug, Markus Hecht, Nadja Ebert, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trialsDario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute|July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, C David Fuller, Shalini Moningi, et al.
Journal of Neuro-Oncology|July 21, 2022
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysisAnna-Luisa Luger, Sven König, Patrick Felix Samp, et al.
International Journal of Cancer|May 9, 2017
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Panagiotis Balermpas, Franz Rödel, Mechthild Krause, et al.
Plos One|April 29, 2017
An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouseVeerle Kersemans, John S Beech, Stuart Gilchrist, et al.
Cancer Cell|February 5, 2022
Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancerAdele M Nicolas, Marina Pesic, Esther Engel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Performance Status Restriction in Phase III Cancer Clinical TrialsJoseph Abi Jaoude, Ramez Kouzy, Walker Mainwaring, et al.
JAMA Oncology|November 18, 2021
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical TrialEmmanouil Fokas, Anke Schlenska-Lange, Bülent Polat, et al.
International Journal of Cancer|December 14, 2017
Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Stefan Stangl, Nikoletta Tontcheva, Wolfgang Sievert, et al.
Pageof 16